271 related articles for article (PubMed ID: 2986368)
1. Technetium 99m-pyrophosphate scintigraphy in amyloid cardiomyopathy.
Ptacin MJ; Bamrah V; Duthie E
Wis Med J; 1985 Mar; 84(3):25-7. PubMed ID: 2986368
[No Abstract] [Full Text] [Related]
2. Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease.
Schiff S; Bateman T; Moffatt R; Davidson R; Berman D
Am Heart J; 1982 Apr; 103(4 Pt 1):562-3. PubMed ID: 6278907
[No Abstract] [Full Text] [Related]
3. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A
G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892
[TBL] [Abstract][Full Text] [Related]
4. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
Gertz MA; Brown ML; Hauser MF; Kyle RA
Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
[TBL] [Abstract][Full Text] [Related]
5. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy].
Hongo M; Misawa T; Yamada H; Hirayama J; Okubo S; Fujii T; Kusama S; Ikeda S
Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):1-8. PubMed ID: 3009667
[No Abstract] [Full Text] [Related]
7. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
[TBL] [Abstract][Full Text] [Related]
8. [Uptake of technetium-99m pyrophosphate in cardiac amyloidosis].
Montes J; López L; Martín F; Pinedo JI; Galván R; Ortiz Berrocal J
Rev Esp Cardiol; 1985; 38(4):300. PubMed ID: 2996085
[No Abstract] [Full Text] [Related]
9. Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85 years and older.
Goldstein SA; Lindsay J; Chandeysson PL; Nolan NG
Am J Cardiol; 1989 Mar; 63(11):752-3. PubMed ID: 2538049
[No Abstract] [Full Text] [Related]
10. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy.
Weston LT; Raybuck BD; Robinowitz M; Brinker JA; Oetgen WJ
Cathet Cardiovasc Diagn; 1986; 12(3):176-81. PubMed ID: 3015411
[TBL] [Abstract][Full Text] [Related]
11. [Cardiac amyloidosis].
Jantunen E; Collan Y; Halinen MO; Kosma VM
Duodecim; 1987; 103(4):192-8. PubMed ID: 3038501
[No Abstract] [Full Text] [Related]
12. [Technetium-99m-pyrophosphate single photon emission computed tomography of the heart in familial amyloid polyneuropathy: comparison with thallium-201 myocardial scintigraphy--a case report].
Imamoto T; Morita K; Onodera S; Tanazawa S; Amoh K; Ishikawa Y; Murakami N; Kawachi H
Kaku Igaku; 1988 Oct; 25(10):1117-23. PubMed ID: 2851670
[No Abstract] [Full Text] [Related]
13. A non-invasive approach to the diagnosis of amyloid cardiomyopathy in elderly patients.
Ptacin M; Bamrah V; Sebastian J; Duthie E
Mil Med; 1986 Feb; 151(2):104-7. PubMed ID: 3008031
[No Abstract] [Full Text] [Related]
14. Scintigraphic characterization of amyloid cardiomyopathy.
Li CK; Rabinovitch MA; Juni JE; Thrall JH; Pitt B; Das SK; Abrams GD; Helvie M
Clin Nucl Med; 1985 Mar; 10(3):156-9. PubMed ID: 2985318
[TBL] [Abstract][Full Text] [Related]
15. A case of disappearing amyloid on technetium pyrophosphate scan.
Wang A; Mahmood U; Tang X; Jain D; Pan S
J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Kumamoto criteria for prediction of
Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
[TBL] [Abstract][Full Text] [Related]
17. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy.
Hongo M; Hirayama J; Fujii T; Yamada H; Okubo S; Kusama S; Ikeda S
Am Heart J; 1987 Mar; 113(3):654-62. PubMed ID: 3030086
[TBL] [Abstract][Full Text] [Related]
18. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis.
Wizenberg TA; Muz J; Sohn YH; Samlowski W; Weissler AM
Am Heart J; 1982 Apr; 103(4 Pt 1):468-73. PubMed ID: 6278906
[TBL] [Abstract][Full Text] [Related]
19. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
20. Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis?
Hartmann A; Frenkel J; Hopf R; Baum RP; Hör G; Schneider M; Kaltenbach M
Int J Card Imaging; 1990; 5(4):227-31. PubMed ID: 2172406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
